Arti Dhar, Ph.D.
Affiliations: | 2011 | Pharmacology | University of Saskatchewan, Saskatoon, SK, Canada |
Area:
Biochemistry, Oncology, Cell BiologyGoogle:
"Arti Dhar"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kash Desai | grad student | 2011 | University of Saskatchewan | |
| (Is methylglyoxal a causative factor for the pathogenesis of type 2 diabetes mellitus and endothelial dysfunction?) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dhar A, Venkadakrishnan J, Roy U, et al. (2023) A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy. Therapeutic Advances in Cardiovascular Disease. 17: 17539447231210170 |
| Dasari D, Goyal SG, Penmetsa A, et al. (2023) Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function. European Journal of Pharmacology. 949: 175720 |
| Dasari D, Bhat A, Mangali S, et al. (2022) Canagliflozin and Dapagliflozin Attenuate Glucolipotoxicity-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Inhibition of Sodium-Glucose Cotransporter-1. Acs Pharmacology & Translational Science. 5: 216-225 |
| Udumula MP, Mangali S, Kalra J, et al. (2021) Publisher Correction: High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin‑3‑hydrazone via downregulation of PKR pathway in Wistar rats. Scientific Reports. 11: 17152 |
| Udumula MP, Mangali S, Kalra J, et al. (2021) High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats. Scientific Reports. 11: 12924 |
| Mangali S, Bhat A, Dasari D, et al. (2021) Inhibition of double stranded RNA dependent protein kinase (PKR) abrogates isoproterenol induced myocardial ischemia in vitro in cultured cardiomyocytes and in vivo in wistar rats. European Journal of Pharmacology. 906: 174223 |
| Kalra J, Dasari D, Bhat A, et al. (2020) PKR inhibitor imoxin prevents hypertension, endothelial dysfunction and cardiac and vascular remodelling in L-NAME-treated rats. Life Sciences. 118436 |
| Mangali S, Bhat A, Jadhav K, et al. (2020) "Upregulation of PKR Pathway Mediates Glucolipotoxicity Induced Diabetic Cardiomyopathy In vivo in Wistar Rats and In vitro in Cultured Cardiomyocytes". Biochemical Pharmacology. 113948 |
| Kalra J, Mangali S, Bhat A, et al. (2019) Selective inhibition of PKR improves vascular inflammation and remodelling in high fructose treated primary vascular smooth muscle cells. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165606 |
| Kalra J, Mangali SB, Dasari D, et al. (2019) SGLT1 Inhibition Boon or Bane for Diabetes Associated Cardiomyopathy. Fundamental & Clinical Pharmacology |